Documents

CS0220

Sigma-Aldrich

Leukotriene B4 EIA

sufficient for 96 tests

Synonym(s):
LTB4
Pricing and availability is not currently available.

usage

sufficient for 96 tests

shipped in

dry ice

storage temp.

−20°C

General description

LTB4 protein in the sample competes with a fixed amount of alkaline phosphatase-labeled conjugate for the limited number of binding sites on the anti-rabbit LTB4 antibody. The antigen-antibody complex binds to the anti-rabbit IgG antibody-coated multiwell plate. The bound enzyme reacts with the substrate and absorbance is read at 405 nm.The intensity of the bound yellow color read at 405 nm is inversely proportional to the concentration of leukotriene in the standards or samples.

Biochem/physiol Actions

Leukotriene B4 stimulates leukocyte functions, lysosomal enzyme release, adhesion and aggregation of polymorphonuclear leukocytes and acts as a mediator of inflammatory diseases and immunoregulation.

Features and Benefits

Specifically measures LTB4 concentrations in cell culture supernatants, urine and other biological fluids with the sensitivity of 19.5 pg/mL. Negligible cross-reactivity with 20-25 related eicosanoid compounds tested (from <0.1 to 2%). Assay offers precoated plates to eliminate the coating step, all incubations proceed at room temperature, reagents are color coded and results are available in 4 hours.
Performance characteristics include low intra- and inter-assay variability and recovery from 99-111%.

Hazard Codes

T

Risk Statement

5-23/24/25-32-34-52/53

Safety Statement

26-36/37/39-45

RIDADR

UN 3316 9/PG 3

Certificate of Analysis
Certificate of Origin

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.